FDA MedWatch News FDA Warnings
 
Ennis & Ennis, P.A. is a national law firm that specializes in mass torts, defective medical devices and product liablity cases. If you have been injured you need to know your legal rights. Contact the lawyers of Ennis & Ennis today for a free case evaluation.
Ennis & Ennis, P.A. News
Free Case Evaluation

FDA MedWatch

Singulair (montelukast): updated information to March 2008 Early Communication

Singulair (montelukast)

Audience: Pulmonologists, respiratory therapists, other healthcare professionals, patients

01/13/2009- FDA provided updated information to its March 2008 Early Communication. FDA is continuing to review clinical trial data to assess other neuropsychiatric events, (mood and behavioral adverse events) related to drugs that act through the leukotriene pathway (montelukast, zafirlukast, zileuton). As a result, FDA has not yet reached a definitive conclusion regarding the clinical trial data on mood and behavioral adverse events associated with montelukast, zafirlukast, and zileuton.

Read the complete MedWatch Safety summary, including a link to the updated early communication and the original March 2008 communication, at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Singulair

________________________________________

You are encouraged to report all serious adverse events and product quality problems for human medical products to MedWatch at: www.fda.gov/medwatch/report.htm.

 

 

 

 

 

 

 

 

 
Required fields in yellow
 
Name:
Email:
 
Telephone: (123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
Please List Defective Product You Are Inquiring About:
Please List Any Side Effects, Injuries, or Property Damage:
Additional Information:
 
 

 

 
Nationwide Free Case Evaluations: 1-800-856-6405